Roehl & Yi Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$647K Buy
8,276
+223
+3% +$18K 0.21% 96
2026
Q1
$698K Sell
8,053
-51
-0.6% -$4.89K 0.26% 79
2025
Q4
$778K Sell
8,104
-33
-0.4% -$3.21K 0.31% 71
2025
Q3
$775K Sell
8,137
-75
-0.9% -$6.89K 0.34% 64
2025
Q2
$716K Sell
8,212
-46
-0.6% -$3.9K 0.37% 62
2025
Q1
$742K Buy
8,258
+349
+4% +$31.2K 0.4% 58
2024
Q4
$632K Buy
+7,909
New +$685K 0.35% 71

Other funds holding MDT

Roehl & Yi Investment Advisors's MDT Position: Q2 2026 in Review

Roehl & Yi Investment Advisors increased its Medtronic (MDT) stake by 2.8% in Q2 2026, buying an estimated $18K and bringing the position to 8,276 shares worth $647K. The position accounts for 0.21% of the portfolio, ranked #96.

Roehl & Yi Investment Advisors first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $778K in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Roehl & Yi Investment Advisors held 8,276 shares of Medtronic worth $647K as of Q2 2026.
  • Roehl & Yi Investment Advisors bought 223 Medtronic shares in Q2 2026, an estimated $18K.
  • Medtronic made up 0.21% of Roehl & Yi Investment Advisors's portfolio in Q2 2026, its #96 holding.
  • Roehl & Yi Investment Advisors first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Roehl & Yi Investment Advisors's Medtronic position peaked at $778K in Q4 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Roehl & Yi Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.